It has been reported that alternative splicing generates two major isoforms of tau containing either 3 or 4 repeats (R) segments, and both forms are detected in the brain of AD and other tauopathies patients; however, few studies were dedicated to the development of therapeutic strategies for targeting these toxic aggregates [59]. This evidence concerns the gene MAPT and Alzheimer disease.